Bio-Med Devices Inc. has been shaping the future of respiratory care for over 50 years, but its story is more than a timeline – it’s a legacy built on family, risk and deep-rooted purpose. The company ...

KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the “Company”), a company engaged in diversified industries, ...

ANN ARBOR, Mich.—Wacker Chemical Corp. has expanded its footprint in the silicone-coated medical space, adding Pennsylvania-based Bio Med Sciences Inc. to its portfolio. Terms of the transaction, ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Bio-Rad Laboratories (BIO) one of those stocks right now? A quick glance at the ...

About Bio Green Med Solution Inc. Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage ...

Add Yahoo as a preferred source to see more of our stories on Google. Some future students at Kent State University might look quite a bit younger than the typical student. Kent State and Bio-Med ...

KENT, Ohio – By the fall of 2027, the Bio-Med Science Academy STEM School will relocate to the Michael Schwartz Center building on Kent State University’s Kent Campus, according to a university news ...

While renewables are all the rage in many applications — or so it seems — bio-based polymers typically are not under material selection consideration for medical devices. One exception to the rule is ...

In an era where the intersection of technology and personal health is more pronounced than ever, the beauty industry is undergoing a significant metamorphosis. As someone who runs a med spa, I've seen ...

Gene Bio Medical, a biotechnology company focusing on the diagnostics and point-of-care testing industries based in Vancouver, is eyeing to expand its geographic exposure worldwide with its current ...

Boehringer Ingelheim exercises option to license additional Dark Antigens from a wider array of tumor types, expanding Enara’s eligibility for milestone payments under existing collaboration Scott ...